Sign up
Pharma Capital

Synlait Milk underwhelming half year result to possibly influence A2 Milk and Bellamy’s

New Zealand listed shares in Synlait opened 12% lower this morning signalling a disappointing result.
share price arrow going down
The net profit of $37.3 million was lower than analyst forecasts

Synlait Milk Ltd (ASX:SM1) (NZE:SML) has this morning released its half-year financial results for the six months ending 31 January 2019.

The dual-listed dairy processing company operating out of New Zealand has revealed net profit of $37.3 million for the half, which is 9.6% lower than the prior corresponding period.

Although net profit was lower in the first half of FY19, the company maintained its previously given guidance that full-year profit will grow compared to FY18 but at a lower rate.

This infers a strong second half for the company.

Synlait also said it remains on track to deliver canned infant formula volume of 41,000-45,000 tonnes with significantly higher volumes forecast in the second half.

It is possible that Synlait’s half-year result has influence over how other listed producers and sellers of infant formula trade today which includes A2 Milk Company Ltd (ASX:A2M) and Bellamy’s Australia Ltd (ASX:BAL).



Register here to be notified of future SM1 Company articles
View full SM1 profile View Profile
View All

Related Articles

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.